Literature DB >> 13733201

Alterations in pyrimidine metabolism in L5178Y leukemia cells resistant to 6-azauridine.

C A PASTERNAK, G A FISCHER, R E HANDSCHUMACHER.   

Abstract

Entities:  

Keywords:  LEUKEMIA/experimental; NUCLEOSIDES AND NUCLEOTIDES; PYRIMIDINES/metabolism

Mesh：

Substances：

Year:  1961        PMID： 13733201

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.

Authors:  Krzysztof Pyrc; Berend Jan Bosch; Ben Berkhout; Maarten F Jebbink; Ronald Dijkman; Peter Rottier; Lia van der Hoek
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  [The effects of cytostatic agents on short-term cultures (3H-uridine incorporation) and tissue cultures (cell counts) from human tumors (author's transl)].

Authors:  J Mattern; K Wayss; M Volm
Journal:  Arch Gynakol       Date:  1974-05-14

3.  Uridine kinase in embryonic rat liver. Modulation of enzyme activity by 5-azacytidine.

Authors:  J Veselý; A Cihák
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

4.  Specific activities of uridine phosphorylase and uridine kinase in Ehrlich ascites carcinoma cells and 6-azauracil- and 6-azauridine-treated sublines in successive transplant generations.

Authors:  D G Blair; A D Hall
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

Review 5.  Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.

Authors:  An R Van Rompay; Magnus Johansson; Anna Karlsson
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.